Ligand-receptor pair-based signature score derived from on-treatment tumor specimens predicts immune checkpoint blockade response in metastatic melanoma.

ABSTRACT:

SUBMITTER: Zeng H 

PROVIDER: S-EPMC12881185 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature